The ascent of pharma marketing

Pharmaceutical companies with a chief marketing officer are thin on the ground, but their number will shortly see a slight increase thanks to a new appointment at Pfizer.

The pharmaceutical company has recruited Andreas “Drew” Panayiotou from Verily, the life sciences business of Google’s parent company Alphabet, to the new role of biopharma global chief marketing officer.

He will join a short list within pharma of companies with a chief marketing officer, despite the job title – and the responsibilities it comes with – being commonplace within the consumer sector.

Deep Dive: Sales and Marketing Innovation, plus pharma leadership and agency perspectives

Pharmaceutical sales and marketing innovation is the main theme for this issue of pharmaphorum’s digital magazine Deep Dive.

Editor George Underwood has assembled experts from across the pharma industry to get their views on the sector’s biggest trends and what new models are needed for companies to keep pace.

Digital Intelligence in PME, June 2012

June’s PME has been out for a while now so it’s about time I cover my Digital Intelligence blog, which this month leads with the first pharma trade press coverage of the ABPI’s digital working group (ABPI forms new group to help pharma with digital communications).

There’s also a look at a study showing how sending patients text message reminders to take their medicine provided a significant boost to adherence  (Text messaging increases medication adherence).

Then there are mentions in print too for new digital marketing initiatives from Pfizer for Liptor, UCB and Eisai, and US stats on doctors’ use of iPads and smartphones.

• Read June’s PME in full online

Digital Intelligence in PME, May 2012

May’s PME is out and this month my Digital Intelligence blog leads on PwC’s survey on social media in health (One third of consumers use social media for health discussions).

There’s also a report on a pharma website that breaches the Code of Practice, but not its digital marketing rules (Shire website breaches UK pharma code).

Then there are mentions in print too for new digital marketing initiatives from Boehringer Ingelheim, Bayer, Roche and Sanofi.

• Read May’s PME in full online

Webcasting

I successfully avoided multi-tasking meltdown during yesterday’s digital marketing webcast, despite a constant switching between moderating duties, monitoring and responding to the Twitter feed and keeping an eye on the incoming questions.

It was an enjoyable experience and the webcast itself is certainly recommended for readers with an interest in digital pharma marketing.

It has now been archived and can be viewed on InPharm.com and I posted a report on my Digital Pharma blog earlier today that focused on Janssen’s UK social media plans.